Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.

Pharmacogenetics and genomics - 1 Mar 2006

Liou Ying-Jay, Lai I-Ching, Lin Ming-Wei, Bai Ya-Mei, Lin Chao-Cheng, Liao Ding-Lieh, Chen Jen-Yeu, Lin Chih-Yuan, Wang Ying-Chieh

Abstract excerpt

OBJECTIVES: Several studies have indicated the involvement of nitric oxide (NO) in the pathogenesis of tardive dyskinesia (TD), an incapacitating adverse movement disorder associated with long-term antipsychotic treatment. In human brain, the NO could be generated by endothelial nitric oxide synthase (NOS3). In this study, we studied whether the genetic variants in human NOS3 gene is associated with TD in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Dyskinesia, Drug-Induced

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Nitric Oxide Synthase Type III

Share to Odds Ratio

Share to Pharmacogenetics

Share to Promoter Regions, Genetic

Share to Schizophrenia

Source

Identifiers

PMID: 16495774
DOI: 10.1097/01.fpc.0000184958.05775.66

Genes

NOS3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.PMID 16495774Read ↗

Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients.Semantic proximity Read ↗

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients.Semantic proximity Read ↗

Genetic association analysis of neuronal nitric oxide synthase gene polymorphism with tardive dyskinesia.Semantic proximity Read ↗

An association study of tachykinin receptor 3 gene with schizophrenia in the Japanese population.Semantic proximity Read ↗

Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia.Semantic proximity Read ↗

Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population.Semantic proximity Read ↗

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.Semantic proximity Read ↗

Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic PolymorphismsSemantic proximity Read ↗

The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration.Semantic proximity Read ↗

Association study between the neurexin-1 gene and tardive dyskinesia.Semantic proximity Read ↗

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.Semantic proximity Read ↗

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.